Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by losingmyshirton Sep 09, 2021 3:18pm
100 Views
Post# 33834701

2,739 SHARES TRADED X.32 DOES NOT LOOK GOOD

2,739 SHARES TRADED X.32 DOES NOT LOOK GOODARE WE NEARING THE EDGE OF THE CLIFF? WHEN DOES SP PLUMMETT INTO THE BASEMENT?

R107 MIGHT NOT BE OF INTEREST TO THE MEDICAL OR SCIENTIFIC WORLD?  TRADING 2739 SHARES IN A DAY DOES NOT APPEAR AS THOUGH THIS IS ALL IT'S CRACKED UP TO BE.
DO YOU THINK FOR A SECOND THAT BIG PHARMA WOULD MISS OUT ON SOMETHING LIKE R107 IF THEY FELT THAT IT HAD A CHANCE TO MAKE MILLIONS..
THE ONLY TRUE BELIEVERS ARE THE PEOPLE STUCK ON THIS BOARD WITH A MAJOR DEFECIT ON THEIR HANDS AND THEY ARE ONLY PRETENDING TO SUPPORT R107 IN THE HOPE THAT OTHER FOOLS WILL COME ON BOARD AND DRIVE UP THE PRICE TO A POINT WHERE THEY CAN BAIL OUT.

IF I WAS YOU i WOULD CALL BOB FARRELL AND ASK HIM WHAT IS GOING ON.

<< Previous
Bullboard Posts
Next >>